Product Information
WEGOVY 2.4 MG/0.75 ML PEN is a brand product labeled by Novo Nordisk, priced at $435.3257 per ML under NDC 00169452414. Its NADAC has been published 249 times since Sep 22, 2021.
Strength
2.4 mg/.75mL
Manufacturer
Novo NordiskNDC
00169452414
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
SEMAGLUTIDEApproval Type
New Drug (NDA)
FDA Application
NDA215256On Market Since
6/5/2021
Pharmacological Classes
Price Statistics
The NADAC for WEGOVY 2.4 MG/0.75 ML PEN has been published 249 times since Sep 22, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $435.3257 per ML |
|---|---|
| All-time high | $435.4787 (Mar 11, 2026) |
| All-time low | $431.7439 (May 17, 2023) |
| 52-week high | $435.4787 |
| 52-week low | $434.5981 |
| Median price | $433.5856 |
| Average price | $433.3731 |
| Largest weekly change | -0.5% (Jul 20, 2022) |
| Weeks tracked | 249 |
| Tracking since | Sep 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the semaglutide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of WEGOVY 2.4 MG/0.75 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for WEGOVY 2.4 MG/0.75 ML PEN, manufactured by Novo Nordisk, is $435.3257 per ML (NDC 00169452414), effective Jun 24, 2026.
How has the price of WEGOVY 2.4 MG/0.75 ML PEN changed over time?
Over the history we have for it, the NADAC for WEGOVY 2.4 MG/0.75 ML PEN has held within roughly two percent of its current level. It has been tracked across 249 weekly CMS publications since Sep 22, 2021.
What are the highest and lowest recorded NADAC prices for WEGOVY 2.4 MG/0.75 ML PEN?
Since Sep 22, 2021, the NADAC for WEGOVY 2.4 MG/0.75 ML PEN has ranged from a low of $431.7439 (May 17, 2023) to a high of $435.4787 (Mar 11, 2026), with a median of $433.5856 per ML.
Are there cheaper alternatives to WEGOVY 2.4 MG/0.75 ML PEN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of WEGOVY 2.4 MG/0.75 ML PEN, so no direct lower-cost alternative is listed.
Who manufactures WEGOVY 2.4 MG/0.75 ML PEN?
WEGOVY 2.4 MG/0.75 ML PEN (NDC 00169452414) is labeled by Novo Nordisk, and CMS classifies it as a brand product.
Related Drugs
Same classification